Cardiac Safety: Key issues and best practice for Thorough QT Studies and Intensive Phase I QT Studies

Cardiac Safety: Key issues and best practice for Thorough QT Studiesand Intensive Phase I QT Studies~ A specialist workshop sponsored by Richmond Pharmacology ~

As collaborating sponsors of the joint AMIFE IFAPP 16th International Conference on Pharmaceutical Medicine � ICPM 2012, Richmond Pharmacology welcomes attendees to join its specialist workshop on Day 2, 15 Nov exploring �Cardiac Safety: Key issues and best practice for Thorough QT Studies and Intensive Phase I QT Studies�.Co-chaired by the internationally acclaimed experts Beno�t Tyl, Georg Ferber and Jorg Taubel, the workshop will look at the biological background to the ICH E14 guidance. They will present the rationale of the thorough QT study and discuss the key elements of a state of the art design and analysis of such a study. The second half of the workshop will address the placement of the TQT study in clinical development and give an update on current CSRC discussions and on conditions under which regulators may be likely to waive a TQT study at present and in future.Attendees are encouraged to submit questions or current problems they may wish the panel to address during the roundtable discussions in advance to:info@richmondpharmacology.comView ICPM 2012 Scientific ProgramRegister for this conference